Saniona AB (publ)
SSE:SANION.ST
Overview | Financials
Company Name | Saniona AB (publ) |
Symbol | SANION.ST |
Currency | SEK |
Price | 2.105 |
Market Cap | 225,801,245 |
Dividend Yield | 0% |
52-week-range | 1.962 - 10.526 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jorgen Drejer Ph.D. |
Website | https://www.saniona.com |
An error occurred while fetching data.
About Saniona AB (publ)
Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD